ENDRA Life Sciences (NDRA) Construction in Progress (2019 - 2024)
ENDRA Life Sciences' (NDRA) quarterly Construction in Progress came in at $125153.0 in Q3 2024, down 11.0% year-over-year from $140617.0 in Q4 2023, and little changed quarter-over-quarter from $125151.0 in Q2 2024.
Analysis
ENDRA Life Sciences (NDRA) Construction in Progress (2019 - 2024) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Construction in Progress for 6 consecutive years, with $125153.0 the latest figure, recorded in Q3 2024.
- On a quarterly basis, Construction in Progress fell 11.0% year-over-year to $125153.0 in Q3 2024; TTM through Sep 2024 was $125153.0, a 11.0% decrease from a year earlier, with the FY2023 full-year figure at $125151.0, down 11.0% from the prior year.
- Construction in Progress was $125153.0 for Q3 2024 at ENDRA Life Sciences, roughly flat from $125151.0 in the prior quarter.
- Over five years, Construction in Progress peaked at $143482.0 in Q2 2022 and troughed at $79207.0 in Q4 2020.
- A 5-year average of $126508.4 and a median of $125153.0 in 2024 frame the typical range for Construction in Progress.
- Across the five-year window, Construction in Progress jumped 81.68% in 2020 and fell 11.0% in 2023, its largest moves.
- Over 5 years, Construction in Progress stood at $79207.0 in 2020, then surged by 35.95% to $107682.0 in 2021, then soared by 30.59% to $140617.0 in 2022, then fell by 11.0% to $125151.0 in 2023, then gained by 0.0% to $125153.0 in 2024.
- The last three Construction in Progress figures came in at $125153.0 (Q3 2024), $125151.0 (Q2 2024), and $125151.0 (Q1 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | - |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | - |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | 69.80 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | - |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | - |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | - |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | - |
| 10 | ENDRA Life Sciences | 8.25 Mn | 2.71 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 125,153.00 |
| Jun 30, 2024 | 125,151.00 |
| Mar 31, 2024 | 125,151.00 |
| Dec 31, 2023 | 125,151.00 |
| Sep 30, 2023 | 140,617.00 |
| Jun 30, 2023 | 140,617.00 |
| Mar 31, 2023 | 140,617.00 |
| Dec 31, 2022 | 140,617.00 |
| Sep 30, 2022 | 143,482.00 |
| Jun 30, 2022 | 143,482.00 |
| Mar 31, 2022 | 107,682.00 |
| Dec 31, 2021 | 107,682.00 |
| Dec 31, 2020 | 79,207.00 |
| Dec 31, 2019 | 43,596.00 |